3 biotech stocks with potential for further growth

July is the month of barbecues and holidays. For many people, it is a time of relaxation and time off from difficult decisions, including investment ones. But analysts think they have a solution for those investors who want to invest in biotech stocks with minimal deliberation.

Three major biotech companies, Eli Lilly, Regeneron Pharmaceuticals and Vertex Pharmaceuticals, dominate the market with their innovative drugs and strong research focus. According to analysts, each of these companies represents a unique investment opportunity with a wide range of growth catalysts that can deliver attractive returns over the long term.

Eli Lilly $LLY

David Jagielski considers Eli Lilly one of the best growth stocks on the market. This pharmaceutical company offers a broad portfolio of growth catalysts, including the diabetes drug Mounjaro and the recently approved weight-loss drug Zepbound. Together, these products brought in $2.3 billion in the first three months of the year.

Mounjaro is now the…